Non-lean versus lean MASLD in adults with type 2 diabetes — a clinical research article previewing comparative patient profiles and cardiorenal-metabolic associations.
Key Takeaways
- Non-lean MASLD patients had higher rates of cardiovascular events than lean MASLD patients
- Non-lean MASLD was independently associated with advanced chronic kidney disease stages with OR = 2.674
- Non-lean MASLD showed greater visceral fat, insulin resistance, and C-peptide levels than lean MASLD